Ledger.Open graph →
SEC Form D · filed January 23, 2015

REGENXBIO Inc

Offering
$30.0M
Sold
$27.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WASHINGTON, Washington, D.C.
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

John D. Kiser · Washington, Washington, D.C.DirectorBenjamin T. Auspitz · Washington, Washington, D.C.DirectorKenneth T. Mills · Washington, Washington, D.C.Exec · DirectorAllan M. Fox · Washington, Washington, D.C.DirectorDonald J. Hayden, Jr · Washington, Washington, D.C.DirectorKenneth T. Mills · Washington, Washington, D.C.Exec · DirectorJohn D. Kiser · Washington, Washington, D.C.DirectorAllan M. Fox · Washington, Washington, D.C.DirectorBenjamin T. Auspitz · Washington, Washington, D.C.DirectorDonald J. Hayden, Jr · Washington, Washington, D.C.Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗